Yanxiang Guo, PhD

Research Project:
Role of Ketogenic Diet in KRAS-mutant Lung Tumor

Grant Awarded:

Lung Cancer Discovery Award

Research Topics:

basic biologic mechanisms
combination therapies experimental therapeutics
immunology immunotherapy

Research Disease:

lung cancer

Ketogenic diet has been proposed as a novel, nontoxic, cost-effective adjuvant therapy in combination with chemotherapy and radiation therapy in the treatment of cancer. However, the role of ketogenic dietary interventions in cancer treatment remains controversial due to insufficient preclinical mouse studies and imperfect clinical trial designs. In preclinical mouse models, our preliminary studies of different subgroups of non-small cell lung cancer with mutations in the KRAS gene exhibit differential responses to a ketogenic diet in tumor growth. We will further elucidate the underlying mechanisms and determine whether the ketogenic diet can serve as an adjuvant to cancer therapy in the treatment of KRAS-mutant non-small cell lung cancer, a type of lung cancer with the lowest survival, worse prognosis and poor response rates to standard cancer treatments.

Page last updated: October 3, 2023

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Yanxiang Guo, PhD

A Breath of Fresh Air in Your Inbox

Thank You!

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA